-
Innovative Tech For Your Health Care Supply Chain — Medically Necessary
Friday, June 25, 2021 - 2:07pm | 288Read More...This show is brought to you by Ryder, the only fully integrated logistics & transportation provider in the industry. Ryder's solutions cover the entire supply chain including warehousing, transportation logistics, e-commerce fulfillment, & last mile. Discover how Ryder can make you ever...
-
CVS, Walgreens, Rite Aid Shares Fall On Report Of Potential Amazon Entry Into Retail Pharmacy
Wednesday, May 26, 2021 - 4:28pm | 283Read More...CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a Business Insider report that Amazon (NASDAQ: AMZN) is considering entering the physical pharmacy retail space. The story's three unnamed sources, who were not authorized to...
-
GoodRx Holdings IPO: What Investors Need To Know
Tuesday, September 22, 2020 - 4:00pm | 682Read More...Prescription pricing platform GoodRx Holdings will hit the public markets this week. The Filing: Good Rx Holdings (NASDAQ: GDRX) plans to sell 34.6 million shares in a pricing range of $24 to $28. At a pricing of $26, the company will be valued at around $10 billion based on over 384 million shares...
-
Traders Sell The News In Omnicare: CVS Confirms Deal To Purchase At $98/Share In Cash
Thursday, May 21, 2015 - 8:38am | 374Read More...Media reports surfaced on Wednesday that CVS Health Corp (NYSE: CVS) was in advanced talks to acquire Omnicare, Inc. (NYSE: OCR) and could finalize a deal by the end of the week. Shares of Omnicare spiked higher by more than 5 percent to the $100 level during Wednesday's post-market trading...
-
Walgreens vs. Rite Aid: Which is the Better Bet?
Monday, January 6, 2014 - 4:56pm | 675Read More...When it comes to buying stocks, everyone wants to pick a winner. But when investors are faced with two very similar stocks for competing companies in the same market it can be challenging to choose the best one. The drug store market has seen several companies perform well on Wall Street but...
-
GlaxoSmithKline Rocked By China Bribery Scandal
Thursday, December 19, 2013 - 4:48pm | 285Read More...A bribery scandal in China is forcing GlaxoSmithKline (NYSE: GSK) to review all of its business practices, The Financial Times reported. Four of GlaxoSmithKline's top Chinese executives have been arrested and dozens more questioned in an ongoing corruption investigation. Chinese police allege...






